Grünenthal uses its own and third-party cookies to improve the browsing experience, offer personalized content and improve its services. We use analytics scripts which set tracking cookie, but we will activate these services only with your consent. If you press the button “Accept”, you consent to the use of these analytics scripts.

You can withdraw your consent at any time. To do so, please modify your configurations on this website by following this link to our privacy statement with the configuration options:
Go to settings

Accept

Media reports about the German Contergan Foundation and Sedalis
;

Press Releases

11/29/2019

We have recorded numerous media reports about the intent of the German Contergan Foundation to cease payments to people affected by "Sedalis". Grünenthal's position on this matter is as follows:

The responsible bodies of the Contergan Foundation decided almost fifty years ago that "Sedalis" is a product that is captured by the Contergan Foundation Law. We see no reason to doubt this assessment. Whilst we disagree with the intent of the Contergan Foundation, we have no influence on it nor were we informed about this intent in advance.

Štěpán Kráčala

Head Global Communications

Grünenthal GmbH


Aachen

E-Mail Stepan.Kracala@grunenthal.com

Phone +49 241 569-1335